The Kansas City region is a global leader at the nexus of human and animal health benefiting all our citizens and the economy.
BioNexus KC believes that together, we can do more to care for people and animals. We inspire thinkers from different disciplines to combine their efforts and bring emerging technologies from conception to reality.
More About BioNexus KC 
Donate to BioNexus KC
22%
The 2018 Life Science Industry Census shows an impressive 22% increase in employment in the life sciences industry in our region since 2015.
For every $1 invested through our research grants, $11.10 is generated in follow-on federal and private funding and returned to the region.
$11.10
26%
STEM students graduating high school entering life science careers earn 26% more than other industry sectors.
Grant Information
Research grants are awarded to encourage regional collaboration and to stimulate the development and submission of major multidisciplinary proposals from life sciences researchers to government or private funding agencies.
A Look Ahead
Kansas City has powerful organizations embedded within an engaged life sciences and healthcare community. With an effective and responsive ecosystem, the KC region will leverage its expertise, assets and determination in fields such as rare disease, informatics and health equity.
A Look Back
We are kicking off our 20th year celebration by highlighting several key life sciences accomplishments in the region. We are proud to bring life sciences organizations together through collaboration and innovation and we look forward to the next 20 years and beyond.
Featured Events
Thank You to our Stakeholder Institutions
Donate to Life Sciences
For Dr. Nasim Ahmadiyeh, @TrumanMedKC, @UMKC, @UMKCmedschool , the challenge is to inspire action within the KC community to utilize mammography to identify #BreastCancer at an earlier stage.
https://vimeo.com/380019877
After a long battle, the question now is not whether to do research with pregnant women, but how to, ethically and efficiently, make up for so much lost ground. Many challenges remain. https://www.scientificamerican.com/custom-media/good-medicine/a-new-face-in-clinical-trials-expecting-mothers/?mvt=i&mvn=a8ef109170414d0ba35b854c1c653ee4&mvp=NA-SCIEAMERLIVE-11237933&mvl=TopicAgenda
Business Council
